Cerebral vasculitis caused by Aspergillus species in an immunocompetent adult

Infection

Volumn 32, Issue 6, 2004, Pages 360-363

  Roberts, M ^a   Carmichael, A ^a   Martin, P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOPHOSPHAMIDE; ETHAMBUTOL; IMMUNOGLOBULIN; ISONIAZID; MEROPENEM; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTERY OCCLUSION; ASPERGILLUS; BASILAR ARTERY; BRAIN ARTERY; BRAIN VASCULITIS; CADAVER; CASE REPORT; FEMALE; HUMAN; IMMUNOCOMPETENCE; PARANASAL SINUS; REVIEW;

AGED; ASPERGILLOSIS; ASPERGILLUS; FEMALE; HUMANS; IMMUNOCOMPETENCE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 12144273100     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-004-3077-1     Document Type: Review

References (14)

1. Siva A: Vasculitis of the nervous system. J Neurol 2001;248: 451-468.
2. Kami M, Shirouzu I, Mitani K, Ogawa S, Matsumura T, Kanda Y, Masumoto T, Saito T, Tanaka Y, Maki K, Honda H, Chiba S, Ohtomo K, Hirai H, Yazaki Y: Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polmerase chain reaction of cerebrospinal fluid. Intern Med 1999;38:45-48.
3. Sarti EJ, Blaugrund SM, Lin PT, Camins MB: Paranasal sinus disease with intracranial extension: aspergillosis versus malignancy. Laryngoscope 1988:632-635.
4. Shapiro K, Tabaddor K: Cerebral aspergillosis. Surg Neurol 1975; 4:465-470.
5. Stammberger H, Jakse R, Beaufort F: Aspergillosis of the paranasal sinuses: x-ray diagnosis, histopathology and clinical aspects. Ann Otol Rhinol Laryngol 1984;93:251-256.
6. deShazo RD, Chapin K, Swain RE: Fungal sinusitis. N Engl J Med 1997;337:254-259.
7. Machetti M, Zotti M, Veroni L, Mordini L, Van Lint MT, Bacigalupo A, Paola D, Viscoli C: Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis 2000;2:140-144.
8. Sutton DA, Slifkin M, Yakulis R, Rinaldi MC: U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropictaxa. J Clin Microbiol 1998;36:708-715.
9. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG: Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002;34:467-476.
10. GuarroJ, Kallas EG, Godoy P, Karenina A, Gene J, Stchigel A, Colombo AL: Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil. Emerg Infect Dis. 2002;8:989-991.
11. Denning DW: Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-615.
12. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandreasekar PH, Hodges MR, Schlamn HT, Troke PF, de Pauw B: Invasive fungal infections group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347: 408-415.
13. Safdar A, Papadopoulos EB, Young JW: Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002;4:212-217.
14. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE: Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391-1402.